Non-Therapeutic Protocol

PKiDS: Pyruvate Kinase Deficiency (PKD)

Type of Protocol/Clinical Study

Associated Hematology Studies : Pyruvate Kinase Deficiency (PKD)


The purpose of this study is to collect information about pyruvate kinase deficiency (PKD), a rare genetic cause of anemia (low red blood count) as not much is known about this deficiency and little formal research has been done to know what the best treatments are. This research is being done to better understand the course of the disease and how patients respond to current treatments that are used.


Primary Aims

Secondary Aims

Eligibility criteria, among others, include:

Inclusion Criteria

Exclusion Criteria

Principal Investigator

Kerri Nottage, MD, MPH

The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.